Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 763-769

  Nie, Lin ^a   Mogami, Hideo ^a   Kanzaki, Makoto ^a   Shibata, Hiroshi ^a   Kojima, Itaru ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; TRANILAST;

ANIMAL CELL; ARTERY INJURY; ARTICLE; AUTOPHOSPHORYLATION; CALCIUM METABOLISM; CALCIUM TRANSPORT; CELL PROLIFERATION; COMPETITIVE INHIBITION; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTHRANILIC ACIDS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; DNA; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 0029979735     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Liu, M. W., G. S. Roubin, and S. B. King. Restenosis after coronary angioplasty. Circulation 79:1374-1380 (1989).
2. Ross, R. The pathogenesis of atherosclerosis. Nature (Lond.) 362:801-809 (1993).
3. Ross, R. The biology of platelet-derived growth factor. Cell 46:155-169 (1986).
4. Barrett, T. B., and E. P. Benditt. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal arterial wall. Proc. Natl. Acad. Sci. USA 85:2810-2814 (1988).
5. Ferns, G. A. A., E. W. Raines, K. H. Sprugel., A. S. Motani., M. A. Reidy, and R. Ross. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDFG. Science (Washington D. C.) 253: 1129-1132 (1991).
6. Claesson-Welsh, L. Platelet-derived growth factor signals. J. Biol. Chem. 269:32023-32026 (1994).
7. Hill, T. D., N. M. Dean, H. Mordan, A. F. Lau, M. Y. Kanemitsu, and A. L. Boynton. PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science (Washington D. C.) 248:1660-1663 (1990).
8. 2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells. J. Biol. Chem. 269:9011-9018 (1994).
9. 2+ entry is blocked by antibodies to phosphatidylinositol 4,5-bisphosphate but does not involve heparin-sensitive inositol 1,4,5,-trisphosphate receptors. J. Biol. Chem. 266:4045-4048 (1991).
10. Mogami, H., and I. Kojima. Stimulation of calcium entry is prerequisite for DNA synthesis induced by PDGF. Biochem. Biophys. Res. Commun. 196: 650-658 (1993).
11. Komatsu, H., M. Kojima, N. Tsutsumi, S. Hamano, H. Kusama, A. Ujiie, S. Ikeda, and M. Nakazawa. Mechanism of inhibitory action of tranilast on the release of SRS-A in vitro. Jpn. J. Pharmacol. 46:53-60 (1988).
12. Tanaka, K., M. Honda, T. Kuramochi, and S. Morioka. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Atherosclerosis 107:179-185 (1994).
13. Kato, K., H. Tamai, H. Hayakawa, T. Yamaguchi, K. Kanmatsuse, K. Haze, T. Aizawa, S. Suzuki, S. Takase, H. Nishikawa, S. Nakanishi, O. Kato, and M. Nakashima (the TREAT Study Investigators). The impact of tranilast on restenosis following coronary angioplasty. Circulation 90:1-652 (1994).
14. Majack, R. A. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell Biol. 105:465-471 (1987).
15. Kojima, I., H. Mogami, N. Kawamura, H. Yasuda, and H. Shibata. Modulation of growth of vascular smooth muscle cells by activin A. Exp. Cell Res. 206:152-156 (1993).
16. McNiel, P. L., M. P. Mckenna, and D. Taylor. A transient rise in cytosolic calcium follows stimulation of quiescent cells with growth factors and is inhibitable with phorbol myristate acetate. J. Cell Biol. 101:372-379 (1985).
17. Minta, A., J. P. Y. Kao, and R. Tsien. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem. 264:8171-8178 (1989).
18. Kojima, I., H. Mogami, and E. Ogata. Oscillation of cytoplasmic free calcium induced by insulin-like growth factor-I. Am. J. Physiol. 262:E307-E311 (1992).
19. Kojima, I., K. Kojima, and H. Rasmussen. Characteristics of calcium influx induced by angiotensin II, potassium and ACTH. J. Biol. Chem. 260:9171-9176 (1985).
20. Burgering, B. M., R. H. Medema, J. A. Maasen, M. L. Wetering, A. J. Eb, F. McCormick, and J. L. Bos. Insulin stimulation of gene expression mediated by p21ras activation. EMBO J. 10:1103-1109 (1991).
21. Satoh, T., W. J. Fantl, J. A. Escobedo, L. T. Williams, and Y, Kaziro. Platelet-derived growth factor receptor mediates activation of Ras through different signalling pathways in different cell types. Mol. Cell. Biol. 13: 3706-3713 (1993).
22. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. Quantitative measurement of sn-1, 2-diacylglycerol present in platelets, hepatocytes and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:8597-8600 (1986).
23. Lowe, P. N., and R. H. Skinner. Regulation of Ras signal transduction in normal and transformed cells. Cell. Signalling 6:109-123 (1994).
24. Rosen, L. B., D. D. Ginty, and M. J. Weber. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 12:1207-1221 (1994).
25. Blumber, K. J., and G. L. Johnson. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19:236-240 (1994).
26. Lee, Y. H., H. S. Kim, J. K. Pai, S. H. Ryu, and P. G. Suh. Activation of phospholipase D induced by platelet-derived growth factor is dependent upon the level of phospholipase C-y. J. Biol. Chem. 269:26842-26847 (1994).
27. Larrodera, P., M. E. Cornet, M. T. Diaz-Meco, M. Lopez-Barahona, I. Diaz-Laviada, P. H. Guddal, T. Johansen, and J. Moscat. Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis. Cell 61:1113-1120 (1990).
28. 2+-permeable channel associated with platelet-derived growth factor receptor in mesangial cells. Am. J. Physiol. 267:C456-C465 (1994).
29. Azuma, H., K. Banno, and M. Nakazawa. Pharmacological properties of N-(3′, 4′-dimethoxy cinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. Br. J. Pharmacol. 58:483-487 (1976).
30. Corcia, A., I. Pecht, S. Hemmerich, S. Ran, and B. Rivnay. Calcium specificity of the antigen-induced channels in rat basophilic leukemia cells. Biochemistry 27:7499-7506 (1988).
31. 2+ conductance found constitutively in B lymphocytes J. Cell Biol. 121:1121-1132 (1993).
32. 1 phase in Balb/c 3T3 cells. J. Biol. Chem. 270:13099-13104 (1995).
33. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol 1,4,5,-trisphosphate. Nature (Lond.) 306:67-68 (1983).
34. Means, A. R. Calcium, calmodulin and cell cycle regulation. FEBS Lett. 347:1-4 (1994).
35. 2+-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J. Biol. Chem. 268:138-145 (1993).
36. Simons, M., K. G. Morgan, C. Parker, E. Collins, and R. D. Rosenberg. The proto-oncogene c-myb mediates an intracellular calcium rise during the late G1 phase of the cell cycle. J. Biol. Chem. 268:627-632 (1993).
37. Benzaquen, L. R., C. Brugnara, H. R. Byers, S. Gattoni-Celli, and J. A. Halperins. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nature Med. 1:534-540 (1995).